Effect of Intravenous Albumin Infusion on Brain Salicylate Concentration

Academic Emergency Medicine

Volumn 14, Issue 6, 2007, Pages 508-514

  Curry, Steven C ^a   Pizon, Anthony F ^a   Riley, Bradley D ^a   Gerkin, Richard D ^a   Bikin, Dale S ^a  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

Author keywords

albumin; brain; pig; poisoning; protein binding; salicylate

Indexed keywords

ALBUMIN; SALICYLATE SODIUM; SODIUM CHLORIDE;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BRAIN LEVEL; INFUSION; INTOXICATION; MALE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; SALICYLATE POISONING; SWINE;

ALBUMINS; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; INFUSIONS, INTRAVENOUS; MALE; POISONING; RANDOM ALLOCATION; SALICYLATES; STATISTICS, NONPARAMETRIC; SWINE;

EID: 34249068819     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2007.01.010     Document Type: Article

References (28)

1. Watson W.A., Litovitz T.L., Klein-Schwartz W., et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 22 (2004) 335-404
2. McGuigan M.A. A two-year review of salicylate deaths in Ontario. Arch Intern Med 147 (1987) 510-512
3. Levy G. Clinical pharmacokinetics of aspirin. Pediatrics 62 (1978) 867-872
4. Hill J.B. Salicylate intoxication. N Engl J Med 288 (1973) 1110-1113
5. Buchanan N., and Rabinowitz L. Infantile salicylism- a reappraisal. J Pediatr 84 (1974) 391-395
6. Curry S.C. Salicylates. In: Brent J., Wallace K.L., Burkhart K.K., Phillips S.D., and Donovan J.W. (Eds). Critical Care Toxicology (2005), Elsevier Mosby, Philadelphia, PA 621-630
7. Reed J.R., and Palmisano P.A. Central nervous system salicylate. Clin Toxicol 8 (1975) 623-631
8. Buchanan N., Kundig H., and Eyberg C. Experimental salicylate intoxication in young baboons. J Pediatr 86 (1975) 225-232
9. Alvan G., Bergman U., and Gustafsson L.L. High unbound fraction of salicylate in plasma during intoxication. Br J Clin Pharmacol 11 (1981) 625-626
10. Ashton J.M., Bolme P., and Zerihun G. Protein binding of salicylic and salicyluric acid in serum from malnourished children: the influence of albumin, competitive binding and non-esterified fatty acids. J Pharm Pharmacol 41 (1989) 474-480
11. MacPherson C.R., Milne M.D., and Evans B.M. The excretion of salicylate. Br J Pharmacol Chemother 10 (1955) 484-489
12. Prescott L.F., Balali-Mood M., Critchley J.A., Johnstone A.F., and Proudfoot A.T. Diuresis or urinary alkalinization for salicylate poisoning?. Br Med J Clin Res Ed 285 (1982) 1383-1386
13. Vree T.B., Van Ewij-Beneken Kolmer E.W., Verwey-Van Wissen C.P., and Hekster Y.A. Effect of urinary pH on the pharmacokinetics of salicylic acid, with its glycine and glucuronide conjugates in human. Int J Clin Pharm Ther 32 (1994) 550-558
14. Hammersborg S.M., Farstad M., Haugen O., Kvalheim V., Onarheim H., and Husby P. Time course variations of haemodynamics, plasma volume and microvascular fluid exchange following surface cooling: an experimental approach to accidental hypothermia. Resuscitation 65 (2005) 211-219
15. Johnson D., Eppler J., Giesbrecht E., et al. Effect of multiple-dose activated charcoal on the clearance of high-dose intravenous aspirin in a porcine model. Ann Emerg Med 26 (1995) 569-574
16. Levy G., and Yaffe S.J. Relationship between dose and apparent volume of distribution of salicylate in children. Pediatrics 54 (1974) 713-717
17. Lee S., Johnson D., Klein J., and Eppler J. Protein binding of acetylsalicylic acid and salicylic acid in porcine and human serum. Vet Hum Toxicol 37 (1995) 224-225
18. Raes A., van Aken S., Craen M., Donckerwolcke R., and Walle J.V. A reference frame for blood volume in children and adolescents. BMC Pediatr 6 (2006) 3. http://www.biomedcentral.com/1471-2431/6/3 Accessed Jan 17, 2007
19. Smith T.W., Butler Jr. V.P., Haber E., et al. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N Engl J Med 307 (1982) 1357-1362
20. Digoxin Immune Fab (Ovine) [product information]. Brentwood, TN: Protherics, Inc.
21. Cory-Slechta D.A., Weiss B., and Cox C. Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy. J Pharmacol Exp Ther 243 (1987) 804-813
22. Valentine J.L., and Owens S.M. Antiphenycyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats. J Pharmacol Exp Ther 278 (1996) 717-724
23. Lamke L.O., and Liljedahl S.O. Plasma volume expansion after infusion of 5%, 20% and 25% albumin solutions in patients. Resuscitation 5 (1976) 85-92
24. Needs C.J., and Brooks P.M. Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet 10 (1985) 164-177
25. Moran M., and Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 317 (1987) 150-153
26. Druml W., Polzleitner D., Laggner A.N., Lenz K., and Ulrich W. Dextran-40, acute renal failure, and elevated plasma oncotic pressure. N Engl J Med 318 (1988) 252-254
27. Rozich J.D., and Paul R.V. Acute renal failure precipitated by elevated colloidal osmotic pressure. Am J Med 87 (1989) 359-360
28. Schnoor J., Schreck R., Baumert J.H., Grosse-Siestrup C., Rossaint R., and Unger J.K. Influence of difference in body weight and volume management on experimental results in porcine models. Int J Artif Organs 27 (2004) 924-934